Experiment 520186

Compounds isolated

Details

PropertyValue
Pharmacology
OrganismEmpty organism
CitationUCKUN,FM: EVANS,WE: FORSYTH,CJ: WADDICK,KG: AHLGREN,LT: CHELSTROM,LM: BURKHARDT,A: BOLEN,J: MYERS,DE:. (1995). BIOTHERAPY OF B-CELL PRECURSOR LEUKEMIA BY TARGETING GENISTEIN TO CD19-ASSOCIATED TYROSINE KINASES.. 267()
Amount utilized
Compound isolated
DiseaseGENISTEIN INHIBITS LYN AND LCK KINASES WHEN IMMUNOCONJUGATED TO MA6 B43.
Dose amount70.0 NANOMOLS
Number1
Qualitative resultACTIVE
Dose expressionCONC USED